A detailed history of Oregon Public Employees Retirement Fund transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 106,564 shares of GILD stock, worth $9.79 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
106,564
Previous 107,024 0.43%
Holding current value
$9.79 Million
Previous $7.34 Million 21.66%
% of portfolio
0.18%
Previous 0.15%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$66.59 - $83.99 $30,631 - $38,635
-460 Reduced 0.43%
106,564 $8.93 Million
Q2 2024

Aug 01, 2024

BUY
$63.15 - $72.88 $30,059 - $34,690
476 Added 0.45%
107,024 $7.34 Million
Q1 2024

May 02, 2024

SELL
$71.58 - $87.29 $4.9 Million - $5.98 Million
-68,497 Reduced 39.13%
106,548 $7.8 Million
Q4 2023

Feb 12, 2024

SELL
$73.27 - $83.09 $11.5 Million - $13.1 Million
-157,418 Reduced 47.35%
175,045 $14.2 Million
Q3 2023

Oct 26, 2023

SELL
$73.94 - $80.67 $7.42 Million - $8.1 Million
-100,413 Reduced 23.2%
332,463 $24.9 Million
Q2 2023

Jul 26, 2023

SELL
$76.01 - $86.7 $4.24 Million - $4.83 Million
-55,767 Reduced 11.41%
432,876 $33.4 Million
Q1 2023

May 04, 2023

SELL
$77.31 - $88.08 $539,623 - $614,798
-6,980 Reduced 1.41%
488,643 $40.5 Million
Q4 2022

Jan 26, 2023

BUY
$62.32 - $89.47 $13.2 Million - $19 Million
212,330 Added 74.95%
495,623 $0
Q3 2022

Nov 01, 2022

SELL
$59.54 - $68.01 $258,879 - $295,707
-4,348 Reduced 1.51%
283,293 $17.5 Million
Q2 2022

Jul 25, 2022

SELL
$57.72 - $65.01 $1.32 Million - $1.49 Million
-22,895 Reduced 7.37%
287,641 $17.8 Million
Q1 2022

Apr 21, 2022

SELL
$57.92 - $72.58 $1.44 Million - $1.81 Million
-24,876 Reduced 7.42%
310,536 $18.5 Million
Q4 2021

Feb 01, 2022

SELL
$64.88 - $73.64 $2.97 Million - $3.37 Million
-45,799 Reduced 12.01%
335,412 $24.4 Million
Q3 2021

Oct 19, 2021

BUY
$67.69 - $73.03 $1.16 Million - $1.25 Million
17,103 Added 4.7%
381,211 $26.6 Million
Q2 2021

Jul 23, 2021

SELL
$63.47 - $69.35 $694,552 - $758,897
-10,943 Reduced 2.92%
364,108 $25.1 Million
Q1 2021

Apr 20, 2021

SELL
$60.0 - $68.46 $863,640 - $985,413
-14,394 Reduced 3.7%
375,051 $24.2 Million
Q4 2020

Feb 09, 2021

SELL
$56.65 - $64.55 $11.5 Million - $13.1 Million
-202,282 Reduced 34.19%
389,445 $22.7 Million
Q3 2020

Nov 03, 2020

SELL
$62.1 - $78.08 $2.37 Million - $2.97 Million
-38,100 Reduced 6.05%
591,727 $37.4 Million
Q2 2020

Jul 21, 2020

BUY
$72.34 - $84.0 $15.6 Million - $18.1 Million
215,154 Added 51.89%
629,827 $48.5 Million
Q1 2020

Apr 20, 2020

SELL
$62.63 - $80.22 $1.67 Million - $2.14 Million
-26,717 Reduced 6.05%
414,673 $31 Million
Q4 2019

Feb 05, 2020

SELL
$61.62 - $67.78 $599,500 - $659,431
-9,729 Reduced 2.16%
441,390 $28.7 Million
Q3 2019

Nov 07, 2019

SELL
$62.51 - $69.0 $284,920 - $314,502
-4,558 Reduced 1.0%
451,119 $28.6 Million
Q2 2019

Jul 16, 2019

SELL
$61.87 - $69.38 $916,047 - $1.03 Million
-14,806 Reduced 3.15%
455,677 $30.8 Million
Q1 2019

May 07, 2019

BUY
$62.53 - $70.05 $440,273 - $493,222
7,041 Added 1.52%
470,483 $30.6 Million
Q4 2018

Feb 07, 2019

SELL
$60.54 - $79.0 $1.73 Billion - $2.25 Billion
-28,524,855 Reduced 98.4%
463,442 $29 Million
Q4 2018

Feb 05, 2019

BUY
$60.54 - $79.0 $1.72 Billion - $2.25 Billion
28,491,386 Added 5733.7%
28,988,297 $463,000
Q3 2018

Oct 30, 2018

BUY
$71.28 - $78.92 $209,777 - $232,261
2,943 Added 0.6%
496,911 $38.4 Million
Q2 2018

Aug 13, 2018

SELL
$64.88 - $75.68 $15 Million - $17.5 Million
-230,898 Reduced 31.85%
493,968 $35 Million
Q1 2018

Apr 12, 2018

BUY
$72.84 - $88.8 $207,084 - $252,458
2,843 Added 0.39%
724,866 $54.6 Million
Q4 2017

Jan 11, 2018

SELL
$71.15 - $83.52 $1.05 Million - $1.23 Million
-14,690 Reduced 1.99%
722,023 $0
Q3 2017

Nov 02, 2017

BUY
$72.11 - $85.47 $53.1 Million - $63 Million
736,713
736,713 $59.7 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.